Advertisement
Screener

ALPHATEC HOLDINGS, INC. (ATEC) Overview

ALPHATEC HOLDINGS, INC. (ATEC) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.16; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.22; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.19; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.27; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$6.64$8.57$11.07$14.29$18.45$23.812025-11-062026-11-06$4.73$6.54$9.03$12.48$17.24$23.812021-11-082026-11-06$1.13$2.08$3.83$7.04$12.95$23.812016-11-072026-11-06$1.13$2.73$6.58$15.86$38.24$92.232006-11-062026-11-06$1.13$2.81$6.98$17.35$43.10$107.102006-06-122026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$7.43
Previous close
$10.37
Change
-$2.94
Change (%)
-28.35%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

ATEC
-50.81%
S&P 500
(m)

1 year

ATEC
-29.84%
S&P 500
(m)

3 years

ATEC
-20.21%
S&P 500
(m)

5 years

ATEC
-16.34%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.16

-0.43-0.32-0.21-0.090.0231 Mar 2025: estimate (m); actual -0.3531 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.2730 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.1930 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.2231 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.1630 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.16(m)(m)
1 Jan 202631 Mar 2026(m)-0.22(m)(m)
1 Jul 202530 Sept 2025(m)-0.19(m)(m)
1 Apr 202530 Jun 2025(m)-0.27(m)(m)
1 Jan 202531 Mar 2025(m)-0.35(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -0.96

-1.62-1.41-1.20-0.99-0.7831 Dec 2021: estimate (m); actual -1.4931 Dec 2021(m)31 Dec 2022: estimate (m); actual -1.4631 Dec 2022(m)31 Dec 2023: estimate (m); actual -1.5431 Dec 2023(m)31 Dec 2024: estimate (m); actual -1.1331 Dec 2024(m)31 Dec 2025: estimate (m); actual -0.9631 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-0.96(m)(m)
1 Jan 202431 Dec 2024(m)-1.13(m)(m)
1 Jan 202331 Dec 2023(m)-1.54(m)(m)
1 Jan 202231 Dec 2022(m)-1.46(m)(m)
1 Jan 202131 Dec 2021(m)-1.49(m)(m)

Revenue vs. Earnings

USD

30 Sept 2018 ■ Revenue 23.00M ■ Earnings -9.36M — Profit margin -40.67%

-13.25M-41.7%0.16M-30.4%13.58M-19.2%26.99M-8.0%30 Sept 2017: revenue 23.10M; earnings -3.14M; profit margin -13.58%30 Sept 201731 Mar 2018: revenue 21.31M; earnings -1.92M; profit margin -8.99%31 Mar 201830 Jun 2018: revenue 22.04M; earnings -7.08M; profit margin -32.10%30 Jun 201830 Sept 2018: revenue 23.00M; earnings -9.36M; profit margin -40.67%30 Sept 2018

31 Dec 2017 ■ Revenue 101.74M ■ Earnings -2.29M — Profit margin -2.25%

-218.67M-134.0%-80.91M-89.7%56.86M-45.5%194.62M-1.3%31 Dec 2014: revenue 154.63M; earnings -12.88M; profit margin -8.33%31 Dec 201431 Dec 2015: revenue 134.39M; earnings -178.68M; profit margin -132.96%31 Dec 201531 Dec 2016: revenue 120.25M; earnings -29.93M; profit margin -24.89%31 Dec 201631 Dec 2017: revenue 101.74M; earnings -2.29M; profit margin -2.25%31 Dec 2017

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$7.43(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$7.43High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning ATEC

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Sept 2018.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-9.29M
Profit margin
-10.03%
Return on assets · 12 month
-8.80%
Index membership
(m)
Employees
913.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
2.38M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
0.28%*
Total return · month
9.98%*
Total return · quarter
8.94%*
Total return · half year
-5.31%*
Total return · year to date
-50.81%*
Total return · 1 year
-29.84%*
Total return · 3 years
-20.21%*
Total return · 5 years
-16.34%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$92.63M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
167.15%*
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

ALPHATEC HOLDINGS, INC. Overview

View more →

(m)

(m)

SEC CIK
1350653
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
1950 CAMINO VIA ROBLE, CARLSBAD, California, United States
Fiscal year end
1231
Phone
760-431-9286

Similar stocks

Stock NameCountryMarket CapPE Ratio
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
NovoCure Ltd (NVCR)$1.886B-11.87
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66